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Background: The use of genetically modified mosquitoes (GMMs) for the control of malaria and other mosquito-borne
diseases has been proposed in malaria-endemic countries, such as Nigeria, which has the largest burden in Africa.
Scientists are major stakeholders whose opinions and perceptions can adversely affect the success of the trials of
GMMs if they are not involved early. Unfortunately, information on the awareness of Nigerians scientists and their
overall perception of the GMMs is practically non-existent in the literature. Therefore, this study aimed at understanding
how receptive Nigerian scientists are to a potential release of GMMs for the control of malaria.
Methods: The sample consisted of 164 scientists selected from academic and research institutions in Nigeria. Data
were collected from participants using a semi-structured, self-administered questionnaire. Questions were asked about
the cause and prevention of malaria, genetic modification and biotechnology. Specific questions on perception
and acceptable conditions for the potential release of GM mosquitoes in Nigeria were also covered.
Results: All participants cited mosquitoes as one of several causes of malaria and used various methods for
household control of mosquitoes. The main concerns expressed by the scientists were that GMMs can spread in
an uncontrolled way beyond their release sites (89%) and will mate with other mosquito species to produce
hybrids with unknown consequences (94.5%). Most participants (92.7%) agreed that it was important that before
approving the release of GMMs in Nigeria, there had to be evidence of contingency measures available to remove
the GMMs should a hazard become evident during the course of the release. In general, a majority (83.5%) of
scientists who participated in this study were sceptical about a potential release in Nigeria, while 16.5% of the
participants were in support.
Conclusions: Although a majority of the participants are sceptical about GMMs generally, most encourage the use
of genetic modification techniques to make mosquitoes incapable of spreading diseases provided that there are
contingency measures to remove GMMs if a hazard becomes evident during the course of the release.
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Malaria is the world’s most important vector-borne disease
and is widespread throughout the tropical and subtropical
regions of the world [1]. It is caused by infection with a
protozoan parasite of the genus Plasmodium and transmit-
ted by Anopheles mosquitoes. In Nigeria, the main vectors
are Anopheles gambiae s.s., Anopheles arabiensis, Anopheles* Correspondence: pnokorie@comui.edu.ng
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unless otherwise stated.melas and Anopheles funestus [2]. Nigeria has the largest
burden of malaria in Africa with over 100 million people
at risk of malaria every year [1,3]. Generally, the strategy
of malaria control is based on chemotherapy and breaking
the chain of transmission of the parasites between humans
and mosquitoes [1]. Currently, malaria vector control
mainly involves the use of insecticide-treated bed nets
(ITNs) and/or long-lasting insecticidal nets (LLINs), and
indoor residual spraying (IRS) [1]. However, malaria con-
trol programmes in Africa have not been very successful
due to widespread insecticide resistance, limited resourcesLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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g/publicdomain/zero/1.0/) applies to the data made available in this article,
Okorie et al. Malaria Journal 2014, 13:154 Page 2 of 8
http://www.malariajournal.com/content/13/1/154and difficulties in implementing the available strategies on
a large scale [4-6]. The failure of existing control measures
has led to interest in the development of new approaches
to reduce the burden of malaria. Several new approaches
involve the use of genetically modified mosquitoes
(GMMs), some of which are engineered to be genetic-
ally sterile and hence induce population suppression,
while others have been engineered such that they are
incapable of transmitting Plasmodium, with the goal
being to spread this trait into a population [5,7-9].
The first open releases of GMMs took place in the
Cayman Islands in 2009 and 2010 where three million
genetically sterile Aedes aegypti mosquitoes, the main
vector of dengue fever, were released with the intention
of reducing their population size [4,5,7,8]. Subsequently,
in 2009–2011, genetically sterile Ae. aegypti mosquitoes
were released in large numbers in Brazil (ten million) as
well as in Malaysia (6,000) [5,7]. The sterile GMMs were
engineered to have a gene that causes 96% of offspring
to die before reaching maturity [8]. The intention here is
that as genetically sterile males mate with wild females,
the reproductive potential of the females will be wasted,
thereby reducing the mosquito population size. In these
trials, released male GMMs were found to be half as suc-
cessful in mating as wild ones and this rate was found to
be sufficient to suppress the population [8]. Another gen-
etically sterile strain of Ae. aegypti was evaluated for its
potential to enhance dengue prevention efforts by indu-
cing population suppression in a large field cage experi-
ment in Mexico [10]. The results here showed that,
although there was a significant decrease in the target
population size, none of the treatment populations were
eliminated, possibly due to a fitness disadvantage associ-
ated with the genetically modified strain [10].
The lessons that have been learnt from the GM crop
controversy in Europe and North America would sug-
gest that for GMMs to be acceptable for malaria control,
scientists need to involve the public prior to trials, as
well as during the research process and the development
of such sophisticated tools [7]. There is much specula-
tion surrounding genetic modification from pressure
groups in various parts of the world and most miscon-
ceptions are a result of lack of accurate information. For
example, Oxford Insect Technologies (Oxitec) faced a
backlash from non-governmental organizations and the
public in the case of release of sterile Ae. aegypti in the
Cayman Islands [7]. Oxitec was criticized for their finan-
cial interest to public health by dealing with GMMs as a
commercial product and releasing the GMMs before
international regulations were set [7,11]. Oxitec was also
accused of not publicly announcing the releases in the
Cayman Islands and deliberately conducting the release
in secret and then publishing the release after a one year
delay [7,12]. GMMs generate debate in many parts ofthe world because of the prospect of releasing flying
transgenic organisms into the environment. Before a field
trial is conducted, it is imperative to find out the attitudes
and concerns of people towards the potential release of
GMMs. Through better communication and transparency
prior to a release in Africa, such controversies like that
generated by the release in Cayman Islands could be
avoided.
Few surveys have been conducted to discover the views
of people towards GMMs for disease control. In a survey
carried out in 2003 and 2004 to gauge attitudes of the
Japanese people to bioethics, a few questions were posed
relating to genetically modified organisms (GMOs) [13].
These surveys focused specifically on whether the use of
GMMs “unable to be a vector for human diseases like
malaria or Japanese encephalopathy” was acceptable to
the Japanese people. The most comprehensive study was a
qualitative survey to determine public attitudes to GMMs
for malaria control in Mali [14]. This survey focused on
GMMs unable to transmit malaria and the “population re-
placement” strategy whereby malaria-refractory transgenes
are linked to a gene drive system capable of manipulating
inheritance in their favour [15]. The authors reported that
participants wanted evidence that GMMs can reduce mal-
aria prevalence without negative consequences to human
health and the environment before they could agree to the
release of GMMs. Recently, a questionnaire survey was
conducted to determine how scientists working on mal-
aria and its vector mosquitoes perceive public opinion and
how they evaluate public consultations in their research
[12]. The results from this study suggest that malaria re-
searchers agree to interact with a non-scientific audience.
Scientists are major stakeholders whose opinions and
perceptions can adversely affect the success of trials of
GMMs if they are not involved early [16].
The opinion of Nigerian scientists on GMMs is critical
to potential trials, not only in the country itself but also
in Africa at large, as Nigeria is the most populous coun-
try in the continent. Apart from providing explanations
and information to the public, scientists are expected to
provide guidance to decision-makers with regard to pol-
icies related to the potential release of GMMs for the
control of malaria [9]. Unfortunately, information on the
awareness of Nigerian scientists and their overall percep-
tion of GMMs is practically non-existent in the litera-
ture. This study aimed to understand how receptive
Nigerian scientists are to the potential release of GMMs
for the control of malaria. The survey addresses the use
of GMMs unable to transmit malaria and the population
replacement strategy whereby transgenes are driven into
a population. Such a strategy is thought to be most ap-
propriate for disease control on a wide scale [15], as it
can be effective beyond the intervention site and over a
long time scale. This is in contrast to sterile GMM
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tion and over a short time period; however, ethical and
regulatory issues must be confronted regarding the
spread of transgenes between communities and across
international borders [17].
Methods
Participants and sampling strategy
A total of 164 scientists were selected from different disci-
plines (science, medicine, agriculture). While participants
were selected to obtain a mixture of backgrounds, only
scientists working in academia, research institutes and ter-
tiary health facilities were interviewed. In brief, two states
in Nigeria (Oyo and Kwara state) were purposively se-
lected from the southern and northern Nigeria respect-
ively. In each state, institutions in the state capital with
scientists working in areas related to Agriculture, Science
and Health sciences were selected. As many scientists
who gave informed consent were interviewed in the two
states. A total of 157 scientist participated in the study in
Oyo state while due to difficulties in obtaining consents,
only seven participants were interviewed in Kwara state.
Questionnaire, measures and data collection
A semi-structured questionnaire was designed and pre-
tested among 60 respondents (scientists) selected from
different institutions in Nigeria. The experiences of the
pre-test were used to refine the final questionnaire used
for the main study. The questionnaire related to general
information on malaria, genetic modification and bio-
technology and included questions on the demographic
characteristics of the participants. Regarding GMMs,
participants were asked to imagine that an organization
from a foreign country claimed they could provide a
GMM capable of reducing malaria morbidity and mor-
tality through population replacement with malaria-
refractory mosquitoes. In addition, they were told that,
to the best of their knowledge, the GMMs were safe, al-
though there could be unknown negative consequences.
Questions were then asked assessing participants’ condi-
tions for approving a release of GMMs in Nigeria, their
specific concerns and general issues about GMM releases
in Nigeria. Scientists’ perceptions were measured using a
five-point Likert scale instrument containing ten items
assessing participants’ perceptions about GMMs (both
negative and positive) developed for this study. The ten
items were gathered from the literature [7,9,12,14,18,19]
and relevant local issues that were considered crucial to
the objectives of this study. The five points were coded as
follows: 1: strongly disagree (SD); 2: disagree (D); 3: neutral
(N); 4: agree (A); and, 5: strongly agree (SA). Data were col-
lected from participants using the semi-structured, self-
administered questionnaire, while trained interviewers
were available in case participants required clarification.Each participant was interviewed independently in a se-
cluded atmosphere by trained interviewers who were
instructed not to provide assistance that could bias or
influence participants’ responses, and only to help par-
ticipants understand the questionnaire should the need
arise.Data management and analysis
Data from collated questionnaires were coded and entered
into the computer system after respondents’ identities
were removed. Data were initially entered into an Excel
spreadsheet and checked for outliers, entry errors and
omissions. The cleaned data were then imported into Stat-
istical Package for Social Sciences (SPSS® version 15)
(SPSS) where further data exploration and cleaning was
performed prior to statistical analysis. Scores for nega-
tively worded perception questions in the perception scale
were recorded in opposite direction to reflect positive per-
ceptions. Perception total scores (PTS) for a participant
were computed as the sum of scores a participant gave to
each question in the ten-item scale (hence minimum and
maximum total score for an individual was ten and 50, re-
spectively). Mean (X ) and standard deviation (SD) of PTS
were computed and PTS < X þ SD were coded 1 (Scep-
tical perception) while PTS≥X þ SD were coded 2 (and
considered positive/supportive perception). Frequency ta-
bles, percentages, means, and standard deviations were
used as descriptive statistics for preliminary data analysis
and explorations [20]. The Chi-squared test was used to
screen for the dependence of GMM perception on se-
lected variables (sex, age, educational level and the all
other variables listed in Additional file 1). In an adjusted
analysis, logistic regression was used to further assess the
variables (number of children, usefulness and risk of
GMMs) found from the chi-square test to significantly as-
sociate with GMM perception among participants (see
Additional file 1). All analyses were performed at 95%
confidence level using SPSS.Ethical clearance
Ethical approval for this study was obtained from the
University of Ibadan and the University College Hospital,
Ibadan (UI/UCH) Ethics Review Committee with ap-
proval number UI/UCH/EC/12/0247. Furthermore, in
line with the guidelines of the institution review com-
mittee, the following ethical issues were addressed: (1)
Confidentiality of data: confidentiality was protected by
using identifying code numbers for each participant. The
survey was anonymous. (2) Beneficence to participants:
The participants’ interest in GMMs were awakened and
they were able to share their views on GMM. (3) Non-
maleficience to the participants: Precautions were taken to
reduce to the barest minimum any form of inconvenience
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A total of 164 scientists completed the self-administered
questionnaire. A majority of the scientists were males
(61.6%) while 36.0% were female (Table 1). A majority
(74.4%) were aged between 30 and 49 years, while 20.7%
were over 49 years. More than three-quarters (86.6%) had
completed advance degrees (MSc: 45.7%; PhD: 40.9%).
Most of those who participated in the study (59.2%) were
scientists with long-standing academic/research experi-
ences (Table 1).
Causes of malaria and malaria protection method
Most of the scientists (97.6%) attributed the cause of mal-
aria to mosquito bites (see Additional file 2) while 41.4%
and 60.4%, respectively considered stress/overwork and
presence of stagnant water as possible causes of malaria.
Of the four respondents that did not include mosquito
bites as the main cause of malaria, none encouraged theTable 1 Sociodemographic characteristics of respondents












4 and above 35 21.3
Not specified 9 5.5
Highest formal educational qualification
First degree/Higher diploma 20 12.2
Masters degree 75 45.7
Doctoral degree 67 40.9
Not reported 2 1.2
Years of experience in academia/research
5 or less 65 39.6
6-15 70 42.7
>15 27 16.5
Not reported 2 1.2use of GMMs for disease control, two (50%) felt it will
never be feasible to release GMMs in Nigeria, while two
(50%) were not sure. Their major concerns about GMMs
included the possibilities of GMM transmitting other dis-
eases, spreading uncontrollably beyond the release sites,
or becoming resistant to insecticides and fogging. Screen-
ing of windows/doors (89.6%), use of aerosols (86.6%), use
of long-lasting insecticidal nets (LLINs) (84.8%) and envir-
onmental management (66.5%) were the most frequently
mentioned malaria preventive methods by the scientists
(see Additional file 2).
Knowledge and perception of genetic modification and
applications of biotechnology
Almost one-third (31.7%) of the scientists had heard or
read a great deal about genetic modification while 60.4%
of them had heard or read about genetic modification
somewhat (see Additional file 2). Some of the participants
(40.2%) had heard about the application of biotechnology
to make mosquitoes unable to transmit diseases; more than
half (56.1%) agreed that mosquitoes unable to transmit dis-
eases would be useful to society, but 17.7% believed that
such technology is risky (see Additional file 2).
Source of information on genetic modification
Figure 1 shows that Nigerian scientists gained information
about GMMs from a variety of sources. The internet
(accounting for 64.3%) was the most popular source of
information while others sourced information on GMMs
from newspapers/bulletins (27.4%) and from conversa-
tions (29.3%) with other scientists.
Scientists’ concerns and recommendations for releasing
GMMs in Nigeria
The main concerns expressed by the scientists were that























Figure 1 Scientists’ sources of information on genetic
modification.
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species to produce hybrids with unknown consequences.
Over 68% of the participants indicated that they were very
concerned with both issues (Table 2). Other major concerns
were that GMMs could transmit other unknown diseases
and may also become resistant to insecticides and fogging
(Table 2). A prominent concern (expressed by 47.6%) was
that GMMs would continue to transmit malaria.
Before deciding whether they approved of GMMs be-
ing released in Nigeria, scientists were asked to rate a
set of recommendations/requirements in order of im-
portance to them (ranging from very important to not
important). A majority (81.5%) felt that “evidence of
contingency measures available to remove GMMs if a
hazard becomes evident during the course of the re-
lease” was very important (Table 3). However, 15.2%
felt provision of bed nets as a requirement for releasing
GMMs in Nigeria was not important.
The most trusted organizations on safety assessment
of GMMs among the scientists were World Health
Organization (WHO) (82.3%) and universities/research
institutes (56.1%) (Table 4). The Nigerian government
was the least trusted (11.0%), with almost half of partici-
pants having no trust at all in the government for a
safety assessment of GMMs release in Nigeria (Table 4).Participants’ perception of GMMs
Negative statements
About 33.9% of the participants agreed that GMMs
would have little effect on malaria, as has been the case
for bed nets and insecticides, which have only slightly
reduced the number of malaria cases in Africa. Some
15.8% agreed that GMMs should not be released as they
would have unknown risks. A very few (12.2%) consid-
ered it likely that there will be horizontal gene transfer
from GMMs to humans, with unknown consequences,
and fewer (7.3%) considered it likely that GMMs may pro-
duce new metabolites or toxins likely to have deleterious
effects on parasites or predators (see Additional file 3).Table 2 Scientists’ concerns for releasing genetically modified
Scientists’ concerns
Concerns about GMM
1. GM mosquitoes can spread in an uncontrolled way beyond their release s
2. GM mosquitoes will mate with other mosquito species producing hybrids with
unknown consequences
3. GM mosquitoes will transmit other unknown diseases
4. GM mosquitoes will become resistant to insecticides and fogging
5. GM mosquitoes will harm the ecosystem
6. GM mosquitoes will be too expensive for developing countries
7. GM mosquitoes will continue to transmit malariaPositive statements
Some 76.2% agreed to approve the release of GMMs but
only if they saw the results of successful laboratory ex-
periments, while 73.2% agreed that it is better to modify
mosquitoes so they cannot transmit diseases since other
methods that have attempted to eradicate mosquitoes
have not worked (see Additional file 3). About 56.1%
strongly agreed that GMMs would improve the quality
of living in developing countries and almost half (48.2%)
agreed that malaria is far worse than any negative conse-
quences that the GMMs might have. In general, a major-
ity (83.5%) who participated in this study were sceptical
about a potential release of GMMs in Nigeria, while
16.5% were in support (see Additional file 2).
Relationship between perception and other factors
Results of the Chi-squared test (see Additional file 1)
shows how the number of children that participants
have significantly correlates with their perception of
GMMs (χ2 = 7.80, p < 0.05). Among participants who
were sceptical about a potential release of GMMs in
Nigeria, the proportion of those with more than four
children (88.6%) was significantly higher than the pro-
portion of those with no children (58.8%). Only 21.3% of
participants had more than four children. Similarly, per-
ception of GMMs was significantly correlated with how
participants considered the usefulness of GMMs (χ2 =
6.40, p < 0.05). Among participants who were sceptical
about a release of GMMs in Nigeria, the proportion of
those who consider GMMs are not useful (94.4%) was
significantly higher than the proportion of those who
consider GMMs useful (77.2%). The adjusted logistic
analysis (at 5% significance level) shows that perception
about GMM was not associated with any factor in this
study.
General questions on genetically modified mosquitoes
In general, 66.5% of the scientists agreed that the use of
genetic modification techniques to make mosquitoes in-
capable of spreading diseases, such as malaria, should bemosquitoes in Nigeria
% of responses
Very concerned A little concerned Not concerned Not sure
ites 68.9 20.1 9.8 1.2
68.3 26.2 4.3 1.2
65.2 28.2 6.1 0.6
64.6 28.2 6.7 0.6
60.4 29.9 9.1 0.6
50.0 33.5 14.6 1.2
47.6 37.2 12.8 1.8









1. Evidence of contingency measures available to remove the GM mosquitoes if a hazard
becomes evident during the course of release
81.7 11.0 1.8 2.4
2. Education campaigns on how GM mosquitoes reduce malaria 78.0 13.4 4.3 2.4
3. A confirmed trial in a community in Nigeria 76.8 10.4 5.5 3.0
4. Scientific evidence that it is possible to reduce malaria using GM mosquitoes 70.7 20.1 4.3 3.0
5. Mosquitoes to be modified captured from our environment 65.2 25.6 4.3 3.7
6. Approval from Nigerian government 65.9 24.4 5.5 1.8
7. Dialogue between Nigerian government, general public and scientists who modify mosquitoes 62.2 22.6 7.3 5.5
8. Evidence from a trial in another African country 62.2 22.6 7.3 5.5
9. Approval from a majority of the Nigerian public 55.5 26.8 15.2 1.2
10. Bed nets provided 51.8 25.0 15.2 5.5
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erence for who should be involved in the modification,
33.9% of the participants preferred local scientists, 37.3%
preferred international scientists, while 25.8% preferred
both local and international scientists to be involved.
About 56% of the scientists think use of GMMs that
are unable to transmit diseases is valuable for the society
while 17.7% think it is risky (see Additional file 2). Gen-
erally, about two-thirds (66.5%) of the scientists agreed
that the use of genetic modification techniques to make
mosquitoes incapable of spreading diseases, such as mal-
aria, should be encouraged. More than half (58.5%)
interviewed thought that it will be feasible to release
GMMs in Nigeria.
Discussion
Public attitudes to disease control strategies using
GMMs are particularly important given the controversy
that has followed trials of GMMs in several countries
[7], and in the light of potentially dangerous health con-












WHO 82.3 11.6 1.8 1.2 3.0
Universities/research
institutes
56.1 37.8 1.8 1.2 3.0




35.4 33.5 20.1 3.7 7.3
Religious bodies 27.4 30.5 16.5 12.2 13.4
Nigerian media 16.5 36 29.9 8.5 9.1
Nigerian government 11 28 49.4 3.7 9.1to gauge whether scientists are open to the potential re-
lease of GMMs and if the technology is acceptable to
them. Indeed, it is essential to engage the community in
early stages of research when new technologies are being
developed and tested so as to get the communities to
accept it [9]. Effort was made in the present study to ob-
tain the overall considerations of Nigerian scientists on a
potential release of GMMs in Nigeria. Although public
surveys were very well received, one must be careful
when interpreting these results. For instance, this survey
was far from a random sample as the selection of partic-
ipants was mainly purposive. Consequently, despite the
rigorous efforts to engage only those participants who
could provide appropriate information in the study, the
results presented here are considered a subset of the
opinion of scientists in Nigeria and their representative-
ness is debatable. Hence, it is impossible to generalize
the findings of the present study to the entire Nigerian
scientists. Non-response bias could be a factor here as
some that did not respond may be more or less support-
ive of GMM technology. Nevertheless, they do provide a
range of perspectives of scientists across the country.
The current findings can inform not only development
of subsequent surveys but also policy decisions regarding
a potential release of GMMs.
As expected, almost all scientists agreed that malaria is
caused by bites from infected mosquitoes. This aware-
ness is high and can likely be attributed to the level of
education and exposure of the respondents. It also sug-
gests that an adequate sample has been taken for the
present study as most of the participants (the scientists)
will have meaningful opinions about mosquito control
methods, and may have thought of alternative mosquito
control methods. Understandably, almost all the respon-
dents perceived mosquitoes to be the main cause of mal-
aria. It was found that the majority of participants had
heard or read something about genetic modification with
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about it. Although the information about their specific
motivations is lacking, it is not surprising to have scien-
tists updating their knowledge on emerging technologies
most especially when it is in the premise of their research
background or interests. On the other hand, less than half
of the participants had heard about the application of bio-
technology to make mosquitoes unable to transmit dis-
eases. This is understandable since no trial of GMMs has
been conducted in Nigeria, although given the back-
ground of these scientists; it suggests that there is low
awareness of GMMs amongst them.
The majority of the participants believed that GMMs
could be useful for malaria control and that the risks in-
volved are minimal. Proponents of malaria-refractory
GMMs have proposed that they have the advantage of be-
ing species-specific, they could reduce the need for the
use of insecticides, they would protect everyone in the re-
lease area, irrespective of socio-economic class or status,
and would require less community involvement in the
control method [4-6,9]. The main concerns of Nigerian
scientists about malaria-refractory GMMs are that they
may spread in an uncontrolled way beyond the release
sites, which may result in hybrid mosquitoes having un-
known consequences. Other major concerns included the
fear that GMMs will transmit unknown diseases and may
become resistant to insecticides and fogging. A less com-
monly expressed concern was that GMMs would continue
to transmit malaria. The modification of mosquitoes such
that they are incapable of spreading disease is risky in the
context of biological adaptability and resistance as little is
known about the behaviour of GMMs in the field [7]. It is
not known how GMMs will respond in terms of behav-
iour, biological fitness and how transgenic mosquitoes will
ultimately impact insect ecology. The use of genetically
modified technology is controversial and some organiza-
tions fear that reliance on such solutions detracts from
more effective but poorly deployed measures to control
disease vectors [7]. These organizations fear that genetic-
ally modified insects could have unintended and wide-
ranging impact on the environment and human health as
they may lead to new public health problems by filling an
ecological niche left by the wild insects that have been
suppressed or eliminated [6]. In particular, there could be
horizontal gene transfer and it may be impossible to re-
verse any damage caused by the introduced genetically
modified insects. The general belief among most commu-
nities is that genetic modification is unnatural and thus
undesirable and this is understandable as use of GMMs
for malaria control involves the release of large numbers
of sterile mosquitoes [6,9].
The most important or popular recommendation/re-
quirement for scientists to approve the release of GMMs in
Nigeria was that there had to be evidence of contingencymeasures available to remove GMMs if a hazard becomes
evident during the course of the release. This implies
that Nigerian scientists may be willing to support the
use of GMMs provided a plan is available that could halt
its use if something went wrong. Education campaigns
on GMMs, a confirmed trial in a community in Nigeria
and scientific evidence that GMMs can reduce malaria
were also important requirements for the scientists.
These requirements are not surprising since the partici-
pants (consisting of people from academia and research
institutes) will most likely require scientific backing for
their actions. Failure to adhere to recommendation by
experts could have negative consequences on the out-
come of some medical and technology trials [7,19].
Most laboratories involved in GMM development are
located in western countries and not in countries where
malaria is endemic and where GMMs may eventually be
released in the field [7]. As this survey has shown, local
scientists prefer to be involved in the development
process and this can remove the need for transfer from
laboratories in the West to the field. This is particularly
encouraging as there has been a call for more scientists
from disease-endemic countries to become involved in
various aspects relating to the use of GMMs for disease
control [9]. There is a need for partnership between sci-
entists in developed and disease-endemic countries [16].
Further, the results of this survey suggest that, despite
scientists in research and academia being knowledgeable,
this does not translate to unconditional support of
GMMs. This is in agreement with the findings in a study
in Mali where Western-trained doctors and scientists
were not more supportive of GMMs or biotechnology
than those in the rural areas with less education [14].
Slightly more than half of the respondents thought that
it would ever be feasible to release GMMs in Nigeria
and, although this is far from a consensus, it is a major-
ity of those interviewed, which is promising for the
technology. However, more than 80% of participants
were sceptical about GMMs, which indicates that there
is strong scepticism over acceptance and tolerance of new
technology [16].Conclusions
Although the majority of participants were sceptical about
GMMs generally, most of them encouraged their use pro-
vided that evidence of contingency measures are available
to remove them should a hazard becomes evident during
the course of the release. While the scenario discussed
here is hypothetical, the results demonstrate the hypoth-
esis set out to test. Nonetheless, there are limitations to be
drawn from public attitudes to a project that has not yet
been carried out as people may respond differently in the
face of reality [9].
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